FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Avila Herbals Did Not Follow Trial Rules: FDA

FDA warns Christiansburg, VA-based Avila Herbals about concerns in its work as a clinical investigator of an investigational drug.

Federal Register

Comments Sought on WHO Drug Scheduling

Federal Register notice: FDA seeks comments on recommendations by the World Health Organization to impose international manufacturing and distributing...

Human Drugs

Clinical Hold on Legend Bio CAR-T Therapy

FDA places a clinical hold against Legend Biotech and its Phase 1 clinical trial for LB1901, an investigational autologous CAR-T cell therapy for trea...

FDA General

Califf Confirmed by Senate in Slim-margin Vote

The U.S. Senate votes 50 to 46 to confirm Robert Califf as the next FDA commissioner.

Medical Devices

FDA Could Improve Device Security: Expert

Aspen Tech Policy Hub fellow Daniel Bardenstein says FDA should require medical device manufacturers to meet a baseline of cybersecurity protections.

Medical Devices

FDA Clears Skin Observation Camera/Scope

FDA clears a Casio America 510(k) for the DZ-D100 DermoCamera and the DZ-S50 scope for skin observation by dermatologists.

Medical Devices

Prostate Cancer Blood Test Gets Breakthrough Status

FDA grants Datar Cancer Genetics a breakthrough device designation for its TriNetra-Prostate blood test to detect early-stage prostate cancer.

Federal Register

Meeting on FDA Hiring/Retention Report

Federal Register notice: FDA announces a 3/15 virtual meeting entitled FDA Hiring and Retention Final Assessment and an opportunity for public comment...

Federal Register

FDA Debars Parks for 5 Years on Unapproved Drug

Federal Register notice: FDA debars Brian Michael Parks for five years from importing or offering for import any article of food (including dietary su...

Human Drugs

FDA Challenges Denali Toxicology Assessment on Alzheimer's Drug

FDA takes issue with Denali Therapeutics preclinical toxicology assessment and requests changes to the clinical trial protocol, the informed consent f...